Skip to main content
OpenTrials
Completed

NCT Number: NCT04699422

Serratus Anterior Plane Block Versus Standard of Care After Totally Endoscopic Aortic Valve Replacement

The aim of this study is to assess and compare the efficacy of a serratus anterior plane (SAP) block and our current pain protocol (Patient Controlled Intravenous Analgesia with opioids) in the prevention and treatment of acute postoperative pain after totally endoscopic aortic valve replacement (AVR) surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Dr Bjorn Stessel

Hasselt, 3500, Belgium

About this study

During the last two decades, cardiac surgical techniques changed dramatically. Evidence for good short and long-term outcome after endovascular and minimally invasive procedures is rising. The goal of avoiding sternotomy is earlier patient recovery without compromising safety. Therefore, enhanced recovery after surgery (ERAS) protocols have been implemented to aim for early extubation and ambulation. Analgesic regimens after cardiac surgery did not change significant however. Opioids remain the cornerstone of analgesia in the postoperative cardiac surgical care units, despite known side effects as nausea, constipation and risk for addiction. Neuraxial anesthetic techniques after cardiac surgery have been studied and validated to reduce opioid consumption. Their implementation in clinical practice however remains limited for two reasons. First, heparinization is required for cardiac surgery, which increases the risk neuraxial hematoma after neuraxial anesthesia, leading to deleterious complications as paraplegia. Secondly, neuraxial anesthesia induces orthosympathicolysis, enhancing vasoplegia after cardiac surgery. However, fascial plane blocks in cardiac surgery since peripheral blocks do not induce sympathicolysis and consequences of chest wall hematoma are limited.

In 2013, Blanco described the serratus anterior plane (SAP) block as an analgesic option for chest wall surgery. In this fascial plane block, local anesthetics are injected in the plane beneath the anterior serratus muscle and in the plane between latissimus dorsi and serratus anterior in an ultrasound guided manner. SAP block provides analgesia in dermatomes T2-T9. Recently, successful analgesia after SAP block has been demonstrated for soft tissue chest wall surgery, thoracotomy and rib fractures. No major side effects were reported. More specifically, no sympatholytic effects or chest wall hematoma were observed. However, up to now no prospective studies assessing the analgesic efficacy of SAP block after cardiac surgery are published. Two retrospective studies show conflicting results. Berthoud et al. retrospectively compared SAP block to continuous wound infusion after different types of minimally invasive cardiac surgery (MICS) and found reduced morphine consumption as well as shorter intensive care and hospital length of stay after SAP block. In contrast, Moll et al. found no difference in opioid consumption between SAP block and no block in patients after robotic coronary artery bypass grafting (rCABG). The authors comment they only performed the deep component of the SAP block, and some surgical entry points were outside dermatomes T2-T7.

Totally endoscopic aortic valve replacement (AVR) is a novel minimally invasive cardiosurgical technique. Surgical incision is made anteriorly in intercostal space two on the right hemithorax. Since intercostal space two is innervated by dermatomes T2-T3, somatic analgesia can be obtained with SAP block. In addition with a favorable safety profile and a minimal/non-existent risk of evoking sympatholytic effects, a SAP block may be a suitable analgesic technique to prevent/minimize postoperative pain after totally endoscopic AVR surgery.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Scheduled for elective aortic valve replacement surgery via right anterolateral thoracotomy
  • Adult patients (minimally 18 years old)
  • EuroScore ii < 3%
  • Bodyweight > 50 kg

Exclusion criteria

  • Refusal to participate
  • Inability to communicate due to language or neurologic barriers
  • Inability to control and self-administer opioids with PCIA or to comprehend the NRS pain score due to confusion or learning difficulties
  • Chronic use of opioids
  • Chronic use of analgesic antidepressants and/or antiepileptics
  • History of major trauma or surgery to right chest wall
  • History of chronic pain at right chest wall
  • Allergy to opioids and/or local anesthetics
  • Allergy to acetaminophen
  • Morbid obesity (BMI > 35)
  • Pregnancy
  • Peroperative events compromising early postoperative recovery (aortic dissection, systolic anterior motion of the mitral valve, cardiac tamponade, ..)

Treatment and study plan

Serratus Anterior Plane Block

Procedure

The needle will be introduced in-plane from supero-anterior to postero-inferior until the needle tip is positioned in the plane underneath the serratus muscle (deep compartment). Under continuous ultrasound guidance,30 cc Bupivacaine 0.25% will be injected in the deep compartment. After the deep component of the SAP is completed, the needle will be withdrawn to the subcutaneous tissues. The needle will be flattened and advanced in-plane to the plane superficial to the serratus muscles. 10 cc Bupivacaine 0.25% will be injected superficial to the serratus muscles after correct placement of the needle tip is confirmed on ultrasound

PCIA with Piritramide

Drug

A patient controlled intravenous analgesia system (IVAC PCAM®, Cardinal Health or CADD pump) with piritramide (Dipidolor®, Janssen) using following settings: bolus 2 mg and lockout interval 15 min.

Other names: PCIA with Dipidolor

Primary outcomes

  1. Cumulative opioid consumption by patient-controlled intravenous analgesia (PCIA)

    Time frame: 24 hours after performing the SAP block

    Piritramide consumption (mg) will be directly read from the PCIA-system after 24 hours.

Secondary outcomes

  1. Opioid consumption during predetermined time intervals after surgery

    Time frame: Every 4 hours until 24 hours after placement of the SAP block

    Piritramide consumption (mg) will be directly read from the PCIA-system at predetermined time intervals after performing the SAP block.

  2. Opioid free patients first 24 postoperative hours

    Time frame: First 24 hours

    Number of patients that do not require any opioids within the first 24 hours after surgery.

  3. Opioid free patients during hospital length of stay

    Time frame: Through study completion, an average of 7 days

    Number of patients that do not require any opioids during the hospital length of stay

  4. Postoperative pain score in rest

    Time frame: 4, 8, 12, and 24 hours after performing the SAP block and at postoperative day 7.

    The postoperative pain on the surgical site is evaluated based on an 11-points numeric scale (Numerical Rating Sale - NRS) where 0 = no pain and 10 = worst pain ever.

  5. Quality of recovery after totally endoscopic aortic valve replacement

    Time frame: Postoperative days 2 and 7

    Quality of recovery will be assessed via the 5-Dimensional European Quality of Life (EQ5D) and 36-Item Short Form Health Survey (SF-36) questionnaires concerning mobility, self care, daily activities and pain.

  6. Overall patient satisfaction with analgesic therapy

    Time frame: 24 hours after performing the serratus anterior plane block at postoperative day 1

    Overall patient satisfaction with analgesic therapy will be assessed with an 11-point Numeric Rating Scale (where 0 = not satisfied at all and 10 = extremely satisfied).

  7. Postoperative nausea and vomiting (PONV)

    Time frame: 24 hours after performing the serratus anterior plane block at postoperative day 1

    The simplified postoperative nausea and vomiting (PONV) impact scale will be used to assess PONV. The scale ranges from 0 to 6, where 0 means no nausea/vomiting. Clinically important PONV will be defined as a score of 5 or more.

  8. Constipation

    Time frame: Until postoperative day 7

    Time to first defecation (postoperative days) or need for laxatives during hospital stay.

  9. Time to extubation

    Time frame: Throughout study completion, an average of 7 days

    Time from arrival to the ICU until extubation in minutes.

  10. ICU length of stay

    Time frame: Until postoperative day 7

    Time from arrival to the ICU until meeting discharge criteria to the ward in postoperative hours.

  11. Hospital length of stay

    Time frame: Through study completion, an average of 7 days

    Time to discharge out of the hospital in postoperative days (day of surgery = day 0)

  12. Pneumonia

    Time frame: Until postoperative day 7

    Defined as empirical antibiotic therapy for suspicion of pneumonia during hospital stay, in number of patients.

  13. Duration of vasopressor infusion

    Time frame: Until postoperative day 7

    Time from arrival to the ICU until full weaning from vasoactive substances (eg norepinephrine) in minutes. Patients not requiring any vasopressors will be excluded from this secondary outcome parameter.

  14. Subcutaneous emphysema

    Time frame: 24 hours after performing the serratus anterior plane block at postoperative day 7

    Number of patients suffering subcutaneous emphysema. All patients will be investigated 24h after performing the SAP block (or control) by a blinded assessor.

  15. Number of patients with new onset perioperative atrial fibrillation (POAF)

    Time frame: Until postoperative day 7

    Number of patients suffering witnessed (ECG recorded) POAF and patients with history of (paroxysmal) atrial fibrillation will not be taken into account for this secondary outcome parameter.

Sponsors and collaborators

Lead sponsor

Jessa Hospital

Other

Registry information

Official study title

Serratus Anterior Plane Block Versus Standard of Care After Totally Endoscopic Aortic Valve Replacement: a Double-blinded Randomized Controlled Trial.

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Jan 7, 2021
Registry last updated
Dec 21, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.